Our study demonstrated an association between genetic polymorphisms in apoptotic pathway gene FASL-844 T>C but not FAS-670 A>G and the susceptibility risk as well as treatment response towards IM in Malaysian CML patients. The gene discussed is FAS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.